Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III THEMIS-PCI results on ticagrelor published

Oct. 3, 2019

XBiotech initiates phase II study of bermekimab in systemic sclerosis

Oct. 3, 2019

Shanghai Allist Pharmaceutical describes new PARP inhibitors

Oct. 3, 2019

New GABRA5 inverse agonists discovered at Shanghai SIMR Biotech

Oct. 3, 2019

Adynxx receives funding award to develop nonopioid chronic pain product candidate

Oct. 3, 2019

Biomica begins preclinical studies with microbial consortia BMC-321 and BMC-322 for IBD

Oct. 3, 2019

Discovery of novel small-molecule inhibitor of PWWP1 domain of NSD3 for acute myeloid leukemia

Oct. 3, 2019

IOCB Prague and Univerzita Palackeho v Olomouci disclose nucleoside derivatives

Oct. 3, 2019

US Department of Health & Human Services and collaborators describe D1 receptor PAMs

Oct. 3, 2019

Shanghai HaiHe Biopharma, Shanghai Institute of Materia Medica patent mutant EZH2 inhibitors

Oct. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...